Eton Pharmaceuticals Inc (ETON)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Eton Pharmaceuticals Inc Stock (ETON) Company Profile

Eton Pharmaceuticals Inc

Healthcare (1104)

(847) 787-7361

21925 W. FIELD PARKWAY, DEER PARK, IL

Prossima data di guadagno

Ultimi documenti SEC

ETON's Discussions on Twitter

Compare ETON vs TAK, HLN, TEVA, ZTS, UTHR

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
ETON Eton Pharmaceuticals Inc	32.48	889.70M	86.93M	-1.48M	431.00K	-0.0709
TAK Takeda Pharmaceutical Co Adr	15.63	49.39B	29.91B	1.30B	3.49B	0.4056
HLN Haleon Plc Adr	8.96	39.55B	14.54B	2.22B	2.58B	0.4871
TEVA Teva Pharmaceutical Industries Ltd Adr	31.48	36.66B	17.53B	1.58B	444.18M	1.3457
ZTS Zoetis Inc	78.71	33.00B	9.51B	2.64B	2.14B	6.0361
UTHR United Therapeutics Corp	536.59	22.78B	3.17B	1.29B	1.01B	27.09

Eton Pharmaceuticals Inc Stock (ETON) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-01-23	Reiterato	H.C. Wainwright	Buy
2025-01-10	Iniziato	B. Riley Securities	Buy
2025-01-06	Reiterato	H.C. Wainwright	Buy
2024-09-04	Ripresa	H.C. Wainwright	Buy
2024-05-06	Iniziato	Craig Hallum	Buy
2021-10-14	Ripresa	B. Riley Securities	Buy
2021-01-04	Reiterato	H.C. Wainwright	Buy
2019-09-20	Iniziato	B. Riley FBR	Buy
2019-06-10	Iniziato	H.C. Wainwright	Buy

Mostra tutto

Eton Pharmaceuticals Inc Borsa (ETON) Ultime notizie

Eton Pharmaceuticals Inc Azioni (ETON) Dati Finanziari

Eton Pharmaceuticals Inc (ETON)

Eton Pharmaceuticals Inc Stock (ETON) Company Profile

Compare ETON vs TAK, HLN, TEVA, ZTS, UTHR

Eton Pharmaceuticals Inc Stock (ETON) Upgrades & Downgrades

Eton Pharmaceuticals Inc Borsa (ETON) Ultime notizie

Eton Pharmaceuticals StockAnalyst targets and biotech peer check - AD HOC NEWS

Eton Pharmaceuticals director Adams sells 50,000 shares for $1.62m - Investing.com UK

Eton Pharmaceuticals Insider Sold Shares Worth $1,623,795, According to a Recent SEC Filing - marketscreener.com

Eton Pharmaceuticals Director Sold Shares Worth Over $1.6M - TradingView

Eton Pharmaceuticals (ETON) director exercises options, sells 50,000 shares in open market - Stock Titan

Eton Pharmaceuticals Inc (ETON) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Eton Pharmaceuticals Inc (ETON) Institutional Confidence - TradingKey

[144] Eton Pharmaceuticals, Inc. SEC Filing - Stock Titan

Eton Pharmaceuticals Inc (ETON) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Eton Pharmaceuticals Inc (ETON) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

ETON Stock Price, Quote & Chart - ChartMill

Eton Pharmaceuticals (ETON) surges 19.8%: Is this an indication of further gains? - MSN

Eton Pharmaceuticals (ETON) Surges 4.75% as Momentum Builds Toward ResistanceWatchlist Stock Ideas - newsline.com

Trading the Move, Not the Narrative: (ETON) Edition - Stock Traders Daily

Eton Pharmaceuticals (NASDAQ: ETON) 2026 vote supports board and auditor - Stock Titan

Eton Pharmaceuticals (ETON) Gains 2.8% as Bullish Momentum Builds Toward ResistanceHigh Beta Stocks - newsline.com

Eton Pharmaceuticals Rallies as Stock Approaches Key Resistance (ETON)Total Put Call - newsline.com

Eton Pharmaceuticals (ETON) Holds Steady Near Resistance With Modest GainDividend ETF - newsline.com

ETON Q1 2026 Earnings: EPS Misses Estimates Despite Narrow ProfitCore Business Growth - newsline.com

Possible Bearish Signals With Eton Pharmaceuticals Insiders Disposing Stock - simplywall.st

ETON: Aggressively scaling rare disease portfolio with strong sales, margin growth, and patient focus - TradingView

Eton Pharmaceuticals (ETON) CFO reports 37,000 employee stock options - Stock Titan

Eton Pharmaceuticals CEO Sean Brynjelsen sells $3.83 million in stock - Investing.com India

Eton Pharmaceuticals Inc (ETON) Shares Fall 4.3% -- What GF Scor - GuruFocus

Eton Pharmaceuticals CEO Sean Brynjelsen sells $3.83 million in stock By Investing.com - Investing.com South Africa

(ETON) Volatility Zones as Tactical Triggers - Stock Traders Daily

Eton Pharmaceuticals (ETON) CEO reports open-market sale of 120,000 shares - Stock Titan

120,000 ETON shares proposed for sale by affiliate (ETON) - Stock Titan

Eton Pharmaceuticals, Inc. $ETON Shares Sold by UBS Group AG - MarketBeat

Eton Pharmaceuticals Insider Sold Shares Worth $3,229,923, According to a Recent SEC Filing - Moomoo

Eton Pharmaceuticals CBO David Krempa sells $3.2m in stock By Investing.com - Investing.com Canada

Eton (ETON) CBO sells 100,000 shares after exercising 87,794 options - Stock Titan

Eton Pharmaceuticals (ETON) soars 6.7%: Is further upside left in the stock? - MSN

ETON SEC FilingsEton Pharmaceuticals 10-K, 10-Q, 8-K Forms - Stock Titan

H.C. Wainwright Remains Bullish on Eton Pharmaceuticals’ (ETON) Growth Strategy - Insider Monkey

Eton Pharmaceuticals Inc (ETON) Shares Fall 6.9% -- GF Value Says Still Overvalued - GuruFocus

ETON (Nasdaq) Rule 144 shows RSUs and Options grants dated 2024–2026 - Stock Titan

5 Oversold Growth Stocks to Invest In Now - Insider Monkey

H.C. Wainwright reiterates Eton Pharmaceuticals stock rating at buy By Investing.com - Investing.com Canada

Earnings call transcript: Eton Pharmaceuticals Q1 2026 shows mixed results By Investing.com - Investing.com Nigeria

Earnings call transcript: Eton Pharmaceuticals Q1 2026 shows mixed results - Investing.com

Eton Pharmaceuticals acquires U.S. rights to leishmaniasis drug By Investing.com - Investing.com India

Eton Pharmaceuticals, Inc.Common Stock (NQ: ETON - The Chronicle-Journal

Eton Pharmaceuticals acquires U.S. rights to leishmaniasis drug - Investing.com

Eton Pharmaceuticals Obtains US Commercialization Rights to Impavido - Moomoo

Eton (NASDAQ: ETON) licenses U.S. IMPAVIDO rights in rare disease push - Stock Titan

Eton Pharmaceuticals Expands Rare Disease Portfolio Through Agreement for U.S. Commercialization Rights to IMPAVIDO® (miltefosine) - The Manila Times

Eton Pharmaceuticals Inc Azioni (ETON) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Simile a ETON